Curis (CRIS) Short Percentage of Float


CRIS Curis Inc CRIS
51 GF Score
Price $6.93
GF Value $1.47
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curis Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

CRIS vs CALC, ICU, TRAW: Short Percentage of Float Comparison

For the Biotechnology subindustry, Curis's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curis Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curis's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Curis's Short Percentage of Float falls into.


CRIS
51GF Score
Curis Inc CRIS
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curis (CRIS) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be overvalued. The current stock price of $6.93 is trading 371.6% above its estimated GF Value™ of $1.47. GuruFocus considers Curis to be Significantly Overvalued.

Key valuation signals for CRIS:

  • Short Percentage of Float:
  • GF Value™: $1.47 vs. price of $6.93 (371.6% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the CRIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curis Business Description

Other Exchanges CUS0:Germany
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
51GF Score

Get the complete analysis for CRIS

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.93
Price
$1.47
GF Value